2009 Annual Meeting | Controversial Issues in Neurologic Infections

Date Monday 04/12/10

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) Israel Steiner, MD

Topic(s)

Learning Objectives Participants should understand the complexities in determining the underlying infections etiology of neurologic disorders through the discussion of a common disorder, Bell's palsy, and the risk of developing a demyelinating disorder following vaccination; and learn the pros and cons of current recommendations for the diagnosis and therapy of acute and chronic infections of the nervous system, including the prerequisites for lumbar puncture, steroids in bacterial meningitis and immune-reconstitution syndrome, and chronic antibiotic therapy in post-Lyme disease. The interactive format will highlight the uncertainties and controversial issues in this important realm.

CME Available No CME available

Core Competencies Interpersonal and Communication Skills, Professionalism, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
06:30 PM - 06:35 PM		Introduction Israel Steiner, MD
06:30 PM - 09:30 PM		Dinner
06:50 PM - 07:15 PM		Herpes Simplex Virus Type 1 in Bell's Palsy Avindra Nath, MD, MBBS, FAAN, Israel Steiner, MD
07:15 PM - 07:40 PM		Imaging Prior to LP in Neurological Infections Karen L. Roos, MD, FAAN, Tom Solomon, MD
07:40 PM - 08:05 PM		Demyelinating Disease After Immunization James J. Sejvar, MD, FAAN, Max Wiznitzer, MD, FAAN
08:15 PM - 08:40 PM		Steroids in Bacterial Meningitis Karen L. Roos, MD, FAAN, Tom Solomon, MD
08:40 PM - 09:05 PM		Antibiotics in Post Lyme Disease Syndrome Joseph R. Berger, MD, FAAN, Israel Steiner, MD
09:05 PM - 09:30 PM		Steroids in Immune Reconstitution Syndrome Joseph R. Berger, MD, FAAN, Avindra Nath, MD, MBBS, FAAN

Faculty Disclosures
Joseph R. Berger, MD, FAAN	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted .
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Karen L. Roos, MD, FAAN	No disclosure on file
Israel Steiner, MD	No disclosure on file
Max Wiznitzer, MD, FAAN	Dr. Wiznitzer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to AAN interests or activities.
James J. Sejvar, MD, FAAN	Dr. Sejvar has nothing to disclose.
Tom Solomon, MD	The institution of Dr. Solomon has received research support from National Institute for Health and Care Research (NIHR).

��ɫ��

��ɫ��